CMPX, NCM
Compass Therapeutics, Inc. (CMPX)
Price (as of October 30)
3.18USD
Correlations
Lowest within Industry
Symbol | Correlation |
---|---|
Arvinas, Inc. |
-0.42 |
BELLUS Health Inc. |
-0.41 |
Atreca, Inc. |
-0.35 |
Cullinan Oncology, Inc. |
-0.34 |
Bellicum Pharmaceuticals, Inc. |
-0.32 |
Arcturus Therapeutics Holdings Inc. |
0.02 |
Arrowhead Pharmaceuticals, Inc. |
0.02 |
Assembly Biosciences, Inc. |
0.04 |
Atara Biotherapeutics, Inc. |
-0.02 |
Bellerophon Therapeutics, Inc. |
-0.13 |
Highest within Industry
Symbol | Correlation |
---|---|
Biomea Fusion, Inc. |
0.26 |
Adicet Bio, Inc. |
0.22 |
Adial Pharmaceuticals, Inc. |
0.21 |
Addex Therapeutics Ltd |
0.2 |
Acurx Pharmaceuticals, Inc. |
0.19 |
Aptinyx Inc. |
0.08 |
Angion Biomedica Corp. |
0.03 |
Akari Therapeutics, Plc |
0.12 |
Alnylam Pharmaceuticals, Inc. |
0.02 |
Seagen Inc. |
0.08 |
Lowest within Industry
Symbol | Correlation |
---|---|
Cullinan Oncology, Inc. |
-0.19 |
Bellerophon Therapeutics, Inc. |
-0.17 |
Arcellx, Inc. |
-0.17 |
BriaCell Therapeutics Corp. |
-0.12 |
Bellicum Pharmaceuticals, Inc. |
-0.11 |
Creative Medical Technology Holdings, Inc. |
-0.09 |
Aprea Therapeutics, Inc. |
-0.05 |
Codiak BioSciences, Inc. |
-0.1 |
BeiGene, Ltd. |
-0.06 |
AN2 Therapeutics, Inc. |
-0.1 |
Highest within Industry
Symbol | Correlation |
---|---|
Recursion Pharmaceuticals, Inc. |
0.15 |
Biomea Fusion, Inc. |
0.12 |
Akouos, Inc. |
0.12 |
Aura Biosciences, Inc. |
0.11 |
BioNTech SE |
0.11 |
Aeglea BioTherapeutics, Inc. |
0.08 |
Acurx Pharmaceuticals, Inc. |
0.09 |
Seagen Inc. |
0.08 |
Adagio Therapeutics, Inc. |
0.1 |
Armata Pharmaceuticals, Inc. |
0.1 |
Lowest within Industry
Symbol | Correlation |
---|---|
Cullinan Oncology, Inc. |
-0.17 |
Arcellx, Inc. |
-0.17 |
Bellerophon Therapeutics, Inc. |
-0.13 |
Codiak BioSciences, Inc. |
-0.1 |
Eterna Therapeutics Inc. |
-0.1 |
AN2 Therapeutics, Inc. |
-0.1 |
Blue Water Vaccines, Inc. |
-0.09 |
Bolt Biotherapeutics, Inc. |
-0.09 |
Creative Medical Technology Holdings, Inc. |
-0.09 |
Bellicum Pharmaceuticals, Inc. |
-0.09 |
Highest within Industry
Symbol | Correlation |
---|---|
Adverum Biotechnologies, Inc. |
0.26 |
ChemoCentryx, Inc. |
0.17 |
Akari Therapeutics, Plc |
0.12 |
Aura Biosciences, Inc. |
0.11 |
Biomea Fusion, Inc. |
0.11 |
Akouos, Inc. |
0.11 |
Armata Pharmaceuticals, Inc. |
0.1 |
Adagio Therapeutics, Inc. |
0.1 |
ADMA Biologics, Inc. |
0.1 |
180 Life Sciences Corp. |
0.1 |
Lowest within Industry
Symbol | Correlation |
---|---|
Cullinan Oncology, Inc. |
-0.17 |
Arcellx, Inc. |
-0.17 |
Bellerophon Therapeutics, Inc. |
-0.13 |
Codiak BioSciences, Inc. |
-0.1 |
Eterna Therapeutics Inc. |
-0.1 |
AN2 Therapeutics, Inc. |
-0.1 |
Blue Water Vaccines, Inc. |
-0.09 |
Bolt Biotherapeutics, Inc. |
-0.09 |
Creative Medical Technology Holdings, Inc. |
-0.09 |
Bellicum Pharmaceuticals, Inc. |
-0.09 |
Highest within Industry
Symbol | Correlation |
---|---|
Adverum Biotechnologies, Inc. |
0.26 |
ChemoCentryx, Inc. |
0.17 |
Akari Therapeutics, Plc |
0.12 |
Aura Biosciences, Inc. |
0.11 |
Biomea Fusion, Inc. |
0.11 |
Akouos, Inc. |
0.11 |
Armata Pharmaceuticals, Inc. |
0.1 |
Adagio Therapeutics, Inc. |
0.1 |
ADMA Biologics, Inc. |
0.1 |
180 Life Sciences Corp. |
0.1 |
Lowest by Sector
Symbol | Correlation |
---|---|
AtriCure, Inc. |
-0.44 |
Arvinas, Inc. |
-0.42 |
BELLUS Health Inc. |
-0.41 |
Bluejay Diagnostics, Inc. |
-0.37 |
Athenex, Inc. |
-0.36 |
Atreca, Inc. |
-0.06 |
Bausch Health Companies Inc. |
-0.1 |
Accelerate Diagnostics, Inc. |
-0.08 |
Cullinan Oncology, Inc. |
-0.17 |
Accuray Incorporated |
-0.02 |
Highest by Sector
Symbol | Correlation |
---|---|
Biomea Fusion, Inc. |
0.26 |
Adicet Bio, Inc. |
0.22 |
Adial Pharmaceuticals, Inc. |
0.21 |
American Well Corporation |
0.2 |
Addex Therapeutics Ltd |
0.2 |
Acurx Pharmaceuticals, Inc. |
0.09 |
Aptinyx Inc. |
0.08 |
Addus HomeCare Corporation |
0.09 |
Aclaris Therapeutics, Inc. |
0.04 |
Angion Biomedica Corp. |
0.03 |
Lowest by Sector
Symbol | Correlation |
---|---|
Cullinan Oncology, Inc. |
-0.19 |
Bellerophon Therapeutics, Inc. |
-0.17 |
Arcellx, Inc. |
-0.17 |
Bausch Health Companies Inc. |
-0.16 |
Biomerica, Inc. |
-0.14 |
Bausch + Lomb Corporation |
-0.13 |
BriaCell Therapeutics Corp. |
-0.08 |
Bellicum Pharmaceuticals, Inc. |
-0.09 |
Creative Medical Technology Holdings, Inc. |
-0.09 |
Aprea Therapeutics, Inc. |
-0.05 |
Highest by Sector
Symbol | Correlation |
---|---|
Acutus Medical, Inc. |
0.15 |
Recursion Pharmaceuticals, Inc. |
0.15 |
IDEXX Laboratories, Inc. |
0.15 |
Smith & Nephew plc |
0.14 |
Biofrontera Inc. |
0.14 |
Intuitive Surgical, Inc. |
0.11 |
Cross Country Healthcare, Inc. |
0.04 |
Biomea Fusion, Inc. |
0.11 |
Teladoc Health, Inc. |
0.1 |
Health Catalyst, Inc. |
0.08 |
Lowest by Sector
Symbol | Correlation |
---|---|
Cullinan Oncology, Inc. |
-0.17 |
Arcellx, Inc. |
-0.17 |
American Shared Hospital Services |
-0.14 |
Bellerophon Therapeutics, Inc. |
-0.13 |
Bausch + Lomb Corporation |
-0.13 |
Biomerica, Inc. |
-0.11 |
Codiak BioSciences, Inc. |
-0.1 |
Bluejay Diagnostics, Inc. |
-0.1 |
Eterna Therapeutics Inc. |
-0.1 |
AN2 Therapeutics, Inc. |
-0.1 |
Highest by Sector
Symbol | Correlation |
---|---|
Adverum Biotechnologies, Inc. |
0.26 |
ChemoCentryx, Inc. |
0.17 |
Biofrontera Inc. |
0.14 |
Amgen Inc. |
0.13 |
Acutus Medical, Inc. |
0.13 |
Akari Therapeutics, Plc |
0.12 |
Atrion Corporation |
0.12 |
Abbott Laboratories |
0.12 |
Amedisys, Inc. |
0.12 |
Intuitive Surgical, Inc. |
0.11 |
Lowest by Sector
Symbol | Correlation |
---|---|
Cullinan Oncology, Inc. |
-0.17 |
Arcellx, Inc. |
-0.17 |
American Shared Hospital Services |
-0.14 |
Bellerophon Therapeutics, Inc. |
-0.13 |
Bausch + Lomb Corporation |
-0.13 |
Biomerica, Inc. |
-0.11 |
Codiak BioSciences, Inc. |
-0.1 |
Bluejay Diagnostics, Inc. |
-0.1 |
Eterna Therapeutics Inc. |
-0.1 |
AN2 Therapeutics, Inc. |
-0.1 |
Highest by Sector
Symbol | Correlation |
---|---|
Adverum Biotechnologies, Inc. |
0.26 |
ChemoCentryx, Inc. |
0.17 |
Biofrontera Inc. |
0.14 |
Amgen Inc. |
0.13 |
Acutus Medical, Inc. |
0.13 |
Akari Therapeutics, Plc |
0.12 |
Atrion Corporation |
0.12 |
Abbott Laboratories |
0.12 |
Amedisys, Inc. |
0.12 |
Intuitive Surgical, Inc. |
0.11 |
Lowest Overall
Symbol | Correlation |
---|---|
Global X MSCI Argentina ETF |
-0.45 |
AtriCure, Inc. |
-0.44 |
TRUESHARES STRUCTURED OUTCOME (AUGUST) ETF |
-0.43 |
Ares Management Corporation |
-0.43 |
ALGER 35 ETF |
-0.43 |
ATI Inc. |
-0.08 |
Bank of the James Financial Group, Inc. |
-0.09 |
Arvinas, Inc. |
-0.02 |
Ares Capital Corporation |
-0.08 |
BELLUS Health Inc. |
-0.06 |
Highest Overall
Symbol | Correlation |
---|---|
A-Mark Precious Metals, Inc. |
0.37 |
Alset Capital Acquisition Corp. |
0.35 |
a.k.a. Brands Holding Corp. |
0.34 |
AdTheorent Holding Company, Inc. |
0.33 |
B&M European Value Retail S.A. |
0.31 |
Digital Turbine, Inc. |
0.13 |
Royal Mail plc |
0.13 |
Electrocomponents plc |
0.1 |
Alibaba Group Holding Limited |
0.1 |
PubMatic, Inc. |
0.14 |
Lowest Overall
Symbol | Correlation |
---|---|
First Trust IndxxMetaverse ETF |
-0.4 |
BYND Cannasoft Enterprises Inc. |
-0.27 |
Pacer BlueStar Engineering the Future ETF |
-0.24 |
FT Cboe Vest Fund of Nasdaq-100 Buffer ETF |
-0.24 |
Austin Gold Corp. |
-0.23 |
AIB Acquisition Corporation |
-0.22 |
Codere Online Luxembourg, S.A. |
-0.19 |
Cullinan Oncology, Inc. |
-0.17 |
Direxion Breakfast Commodities Strategy ETF |
-0.19 |
Banyan Acquisition Corporation |
-0.18 |
Highest Overall
Symbol | Correlation |
---|---|
DigitalOcean Holdings, Inc. |
0.21 |
Lithium Americas Corp. |
0.2 |
Smiths Group plc |
0.19 |
Match Group, Inc. |
0.19 |
Digital Turbine, Inc. |
0.19 |
Belong Acquisition Corp. |
0.18 |
Antelope Enterprise Holdings Limited |
0.16 |
AMREP Corporation |
0.12 |
Benessere Capital Acquisition Corp. |
0.15 |
PubMatic, Inc. |
0.14 |
Lowest Overall
Symbol | Correlation |
---|---|
First Trust IndxxMetaverse ETF |
-0.4 |
BYND Cannasoft Enterprises Inc. |
-0.27 |
Pacer BlueStar Engineering the Future ETF |
-0.24 |
FT Cboe Vest Fund of Nasdaq-100 Buffer ETF |
-0.24 |
Austin Gold Corp. |
-0.23 |
AIB Acquisition Corporation |
-0.22 |
Codere Online Luxembourg, S.A. |
-0.19 |
Bel Fuse Inc. |
-0.19 |
Direxion Breakfast Commodities Strategy ETF |
-0.19 |
Banyan Acquisition Corporation |
-0.18 |
Highest Overall
Symbol | Correlation |
---|---|
Adverum Biotechnologies, Inc. |
0.26 |
Diebold Nixdorf, Incorporated |
0.19 |
DigitalOcean Holdings, Inc. |
0.18 |
Belong Acquisition Corp. |
0.18 |
ChemoCentryx, Inc. |
0.17 |
Athena Technology Acquisition Corp. II |
0.16 |
Apple Inc. |
0.16 |
Antelope Enterprise Holdings Limited |
0.16 |
Benessere Capital Acquisition Corp. |
0.15 |
Coupang, Inc. |
0.15 |
Lowest Overall
Symbol | Correlation |
---|---|
First Trust IndxxMetaverse ETF |
-0.4 |
BYND Cannasoft Enterprises Inc. |
-0.27 |
Pacer BlueStar Engineering the Future ETF |
-0.24 |
FT Cboe Vest Fund of Nasdaq-100 Buffer ETF |
-0.24 |
Austin Gold Corp. |
-0.23 |
AIB Acquisition Corporation |
-0.22 |
Codere Online Luxembourg, S.A. |
-0.19 |
Bel Fuse Inc. |
-0.19 |
Direxion Breakfast Commodities Strategy ETF |
-0.19 |
Banyan Acquisition Corporation |
-0.18 |
Highest Overall
Symbol | Correlation |
---|---|
Adverum Biotechnologies, Inc. |
0.26 |
Diebold Nixdorf, Incorporated |
0.19 |
DigitalOcean Holdings, Inc. |
0.18 |
Belong Acquisition Corp. |
0.18 |
ChemoCentryx, Inc. |
0.17 |
Athena Technology Acquisition Corp. II |
0.16 |
Apple Inc. |
0.16 |
Antelope Enterprise Holdings Limited |
0.16 |
Benessere Capital Acquisition Corp. |
0.15 |
Coupang, Inc. |
0.15 |
Profile
- Sector:
- Healthcare
- Industry:
- Biotechnology
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137. Its product candidates also comprise CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1. The company was founded in 2014 and is headquartered in Boston, Massachusetts.